Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To rigorously evaluate the time course of cognitive change in a cohort of individuals with HIV-associated neurocognitive disorders (HAND) initiating combination antiretroviral therapy (CART), and to investigate which demographic, laboratory, and treatment factors are associated with neuropsychological (NP) outcome (or "any NP improvement"). METHODS: Study participants included 37 HIV+ individuals with mild to moderate NP impairment who initiated CART and underwent NP testing at 12, 24, 36, and 48 weeks thereafter. NP change was assessed using a regression-based change score that was normed on a separate NP-stable group thereby controlling for regression toward the mean and practice effect. Mixed-effect regression models adjusting for loss to follow-up were used to evaluate the time course of cognitive change and its association with baseline and time-varying predictors. RESULTS: In persons with HAND initiating CART, cognitive improvement happens soon after initiation (13% at week 12), but more often 24, 36, and up to 48 weeks after initiation (up to 41%), with fewer than 5% demonstrating significant worsening. In multivariate analyses, unique predictors of NP improvement included more severe baseline NP impairment and higher CART CNS penetration index. Greater viral load decrease was associated with NP improvement only in univariate analyses. CONCLUSION: Clinically meaningful neuropsychological improvement seemed to peak around 24-36 weeks after combination antiretroviral therapy initiation and was prolonged over the 1-year study period. This study also provides new evidence that benefit may be maximized by choosing antiretroviral medications that reach therapeutic concentrations in the CNS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Updated research nosology for HIV-associated neurocognitive disorders
Antinori, A., Arendt, G., Becker, J. T., Brew, B. J., Byrd, D. A., Cherner, M., Clifford, D. B., Cinque, P., Epstein, L. G., Goodkin, K., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000287431.88658.8b · Cited by 2,630
Self-citationLetendre, S. (2008) · Archives of Neurology · doi:10.1001/archneurol.2007.31 · Cited by 825
Self-citationStatistical Methods for the Analysis of Repeated Measurements
Davis, C. S. (2002) · Springer Texts in Statistics · doi:10.1007/b97287 · Cited by 577
Hinkin, C. H., Hardy, D. J., Mason, K. I., Castellon, S. A., Durvasula, R. S., Lam, M. N., & Stefaniak, M. (2004) · AIDS · doi:10.1097/00002030-200418001-00004 · Cited by 551
Carey, C. L., Woods, S. P., Gonzalez, R., Conover, E., Marcotte, T. D., Grant, I., & Heaton, R. K. (2004) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390490510031 · Cited by 544
Self-citationCOLLIE, A., MARUFF, P., DARBY, D. G., & McSTEPHEN, M. (2003) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617703930074 · Cited by 453
Falleti, M. G., Maruff, P., Collie, A., & Darby, D. G. (2006) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390500205718 · Cited by 422
Detecting significant change in neuropsychological test performance: A comparison of four models
TEMKIN, N. R., HEATON, R. K., GRANT, I., & DIKMEN, S. S. (1999) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617799544068 · Cited by 324
Self-citationMcSweeny, A. J., Naugle, R. I., Chelune, G. J., & Lüders, H. (1993) · Clinical Neuropsychologist · doi:10.1080/13854049308401901 · Cited by 269
Heaton, R. (2001) · Archives of Clinical Neuropsychology · doi:10.1016/s0887-6177(99)00062-1 · Cited by 252
Self-citationEnhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders
Letendre, S. L., McCutchan, J. A., Childers, M. E., Woods, S. P., Lazzaretto, D., Heaton, R. K., Grant, I., Ellis, R. J., & the HNRC Group (2004) · Annals of Neurology · doi:10.1002/ana.20198 · Cited by 222
Self-citationPractice and Drop-Out Effects During a 17-Year Longitudinal Study of Cognitive Aging
Rabbitt, P., Diggle, P., Holland, F., & McInnes, L. (2004) · The Journals of Gerontology Series B: Psychological Sciences and Social Sciences · doi:10.1093/geronb/59.2.p84 · Cited by 181
Variable benefit in neuropsychological function in HIV-infected HAART-treated patients
Cysique, L. A. J., Maruff, P., & Brew, B. J. (2006) · Neurology · doi:10.1212/01.wnl.0000210477.63851.d3 · Cited by 149
Self-citationHighly Active Antiretroviral Therapy Improves Neurocognitive Functioning
Robertson, K. R., Robertson, W. T., Ford, S., Watson, D., Fiscus, S., Harp, A. G., & Hall, C. D. (2004) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200405010-00003 · Cited by 148
Levine, A. J., Miller, E. N., Becker, J. T., Selnes, O. A., & Cohen, B. A. (2004) · The Clinical Neuropsychologist · doi:10.1080/1385404049052420 · Cited by 144
McArthur, J. C., McDermott, M., McClernon, D. R., Hillaire, C. S., Conant, K., Marder, K. S., Schifitto, G., Selnes, O. A., Sacktor, N. C., Stern, Y., et al. (2004) · Archives of Neurology · doi:10.1001/archneur.61.11.1687 · Cited by 142
Antiretroviral Therapy in HIV Infection
Cysique, L. A., Maruff, P. T., & Brew, B. J. (2004) · Archives of Neurology · doi:10.1001/archneur.61.11.1699 · Cited by 92
Self-citationThe impact of AIDS on adult mortality
Blacker, J. (2004) · AIDS · doi:10.1097/00002030-200406002-00003 · Cited by 89
McCutchan, J. A., Wu, J. W., Robertson, K., Koletar, S. L., Ellis, R. J., Cohn, S. E., Taylor, M. J., Woods, S. P., Heaton, R. K., Currier, J. S., et al. (2007) · AIDS · doi:10.1097/qad.0b013e3280ef6acd · Cited by 81
Self-citationPractice Effects on the WAIS-III Across 3- and 6-Month Intervals
Basso, M. R., Carona, F. D., Lowery, N., & Axelrod, B. N. (2002) · The Clinical Neuropsychologist · doi:10.1076/clin.16.1.57.8329 · Cited by 80
Efficient hybrid EM for linear and nonlinear mixed effects models with censored response
Vaida, F., Fitzgerald, T., & DeGruttola, V. G. (2006) · Computational Statistics & Data Analysis · doi:10.1016/j.csda.2006.09.036 · Cited by 70
Self-citationFerrando, S. J., Rabkin, J. G., van Gorp, W. G., Lin, S., & McElhiney, M. C. (2003) · Journal of Neuropsychiatry · doi:10.1176/jnp.15.2.208 · Cited by 52
Saitoh, A., Foca, M. D., Viani, R. M., Vacca, S. H., Vaida, F., Luján‐Zilbermann, J., Emmanuel, P. J., Deville, J. G., & Spector, S. A. (2008) · PEDIATRICS · doi:10.1542/peds.2007-1086 · Cited by 42
Self-citation
Cited by
Heaton, R. K., Clifford, D. B., Franklin, D. R., Woods, S. P., Ake, C., Vaida, F., Ellis, R. J., Letendre, S. L., Marcotte, T. D., Atkinson, J. H., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e318200d727 · Cited by 2,353
Self-citationGroups, F. T. C. A. H., Heaton, R. K., Franklin, D. R., Ellis, R. J., McCutchan, J. A., Letendre, S. L., LeBlanc, S., Corkran, S. H., Duarte, N. A., Clifford, D. B., et al. (2011) · Journal of NeuroVirology · doi:10.1007/s13365-010-0006-1 · Cited by 1,533
Self-citationHIV Infection, Inflammation, Immunosenescence, and Aging
Deeks, S. G. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-042909-093756 · Cited by 1,349
Cognitive dysfunction in HIV patients despite long-standing suppression of viremia
Simioni, S., Cavassini, M., Annoni, J.-M., Rimbault Abraham, A., Bourquin, I., Schiffer, V., Calmy, A., Chave, J.-P., Giacobini, E., Hirschel, B., et al. (2010) · AIDS · doi:10.1097/qad.0b013e3283354a7b · Cited by 702
Human immunodeficiency virus‐associated neurocognitive disorders: Mind the gap
McArthur, J. C., Steiner, J., Sacktor, N., & Nath, A. (2010) · Annals of Neurology · doi:10.1002/ana.22053 · Cited by 445
Metadata
- Authors
- Cysique, L. A., Vaida, F., Letendre, S., Gibson, S., Cherner, M., Woods, S. P., McCutchan, J. A., Heaton, R. K., & Ellis, R. J.
- Venue
- Neurology
- Published
- 2009-08-04
- Volume
- 73
- Issue
- 5
- Pages
- 342-348
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2051040572
- Cited by
- 274
- References
- 24
- FWCI
- 8.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.